TScan Therapeutics, Inc.
TCRX· Nasdaq
TCRXTScan Therapeutics, Inc.
Quarterly figures for TScan Therapeutics, Inc., with source filings when available.
25 quarters. Jun 30, 2020 to Jun 30, 2026. USD.
TScan Therapeutics, Inc. has filed its 10-Q within 36 to 43 days of period end across its last 8 quarters. The 10-K runs 63 to 68 days.
TScan Therapeutics, Inc. · CIK 1783328 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 12, 2026 · market hours | Aug 12, 2026 | 43 d | 10-Q | $1.05M | −65.8% | -$0.23 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 6, 2026 · market hours |
| May 6, 2026 |
| 36 d |
| 10-Q |
| $982.00K |
| −54.8% |
| -$0.22 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 4, 2026 · market hours | Mar 4, 2026 | 63 d | 10-K | $2.57M | +286.0% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 · market hours | Nov 12, 2025 | 43 d | 10-Q | $2.51M | +139.4% | -$0.28 | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · market hours | Aug 12, 2025 | 43 d | 10-Q | $3.08M | +473.9% | -$0.28 | |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 · market hours | May 6, 2025 | 36 d | 10-Q | $2.17M | +283.6% | -$0.26 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 5, 2025 · market hours | Mar 5, 2025 | 64 d | 10-K | $665.00K | −90.8% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 · market hours | Nov 12, 2024 | 43 d | 10-Q | $1.05M | −73.0% | -$0.25 | |
| Q2 2024 | Jun 30, 2024 | Aug 12, 2024 · market hours | Aug 12, 2024 | 43 d | 10-Q | $536.00K | −83.0% | -$0.28 | |
| Q1 2024 | Mar 31, 2024 | May 13, 2024 · market hours | May 13, 2024 | 43 d | 10-Q | $566.00K | −91.7% | -$0.32 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 6, 2024 · market hours | Mar 6, 2024 | 66 d | 10-K | $7.21M | +133.0% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 · market hours | Nov 9, 2023 | 40 d | 10-Q | $3.89M | +15.6% | -$0.24 | |
| Q2 2023 | Jun 30, 2023 | Aug 10, 2023 · market hours | Aug 10, 2023 | 41 d | 10-Q | $3.15M | −22.4% | -$0.51 | |
| Q1 2023 | Mar 31, 2023 | May 10, 2023 · market hours | May 10, 2023 | 40 d | 10-Q | $6.80M | +125.2% | -$0.93 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 8, 2023 · market hours | Mar 8, 2023 | 67 d | 10-K | $3.10M | +8.4% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 9, 2022 · market hours | Nov 9, 2022 | 40 d | 10-Q | $3.36M | +39.4% | -$0.67 | |
| Q2 2022 | Jun 30, 2022 | Aug 10, 2022 · market hours | Aug 10, 2022 | 41 d | 10-Q | $4.06M | +42.4% | -$0.63 | |
| Q1 2022 | Mar 31, 2022 | May 9, 2022 · market hours | May 12, 2022 | 42 d | 10-Q | $3.02M | +49.0% | -$0.67 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 9, 2022 · market hours | Mar 9, 2022 | 68 d | 10-K | $2.85M | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 10, 2021 · market hours | Nov 10, 2021 | 41 d | 10-Q | $2.41M | +731.7% | -$0.80 | |
| Q2 2021 | Jun 30, 2021 | Aug 19, 2021 · market hours | Aug 19, 2021 | 50 d | 10-Q | $2.85M | — | -$7.69 | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | $2.03M | — | -$6.49 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $290.00K | — | -$7.16 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | — | — | -$6.18 | |
